MAPT and Alzheimer disease: In the current study, we performed immunohistochemistry and single-nucleus RNA-seq on a recently established humanized AD model (Hashimoto et al., 2019; Saito et al., 2019) with or without the intracranial administration of PART tau, to investigate the effects of tau accumulation on microglial cellular states in the brain.